KRAS and mucinous adenocarcinoma: Chang et al. reported that 90% (9/10) of mucinous adenocarcinomas arising in the CPAM harbored KRAS mutations, including five cases with the KRAS G12D mutation and four cases with the KRAS G12V mutation [2].